Covid19 Resilience: South Africa Moved Up 2 Spots in Best Places to Be in Bloomberg Ranking
- Bloomberg has released new statistics regarding resilience as far as the new Covid-19 variant, Delta, including in South Africa
- The publication listed 53 countries that are resilient to the delta variant and South Africa stands at number 46
- According to the statistics, Mzansi is rated based on the number of people who have been vaccinated
PAY ATTENTION: Click “See First” under the “Following” tab to see Briefly News on your News Feed!
Despite still fighting against the ravaging coronavirus pandemic, South Africa has moved up in terms of rankings as far as the resilience of the new delta variant.
According to Bloomberg, the delta variant has left many economies around the world completely at a standstill. It says the variant has distracted from every model of success that emerged in the past 18 months.
The publication has it that European countries were the most resilient last month and that widespread immunisation played a massive role. Out of 10 countries in Europe, nine were deemed resilient and Norway held the number one spot for two consecutive months.
Source: Getty Images
South Africa’s delta variant ranking improves
According to the publication and the report, Mzansi moved five spots from 51st to 46th out of 53 countries, as per the latest statistics and numbers. The country’s score as rated by Bloomberg stands at 53.8 and that could be credited to a number of people covered by vaccines.
Enjoy reading our stories? Download the BRIEFLY NEWS app on Google Play now and stay up-to-date with major South African news!
Looking at the graphic released by the news site, 11.2% of people in Mzansi have received their jabs.
Health Minister Joe Phahla speaks about the new variant C.1.2
Dr Joe Phahla was speaking during the National Council of Province’s Ministerial Briefing Session on the vaccination programme. He said as quoted by BusinessTech:
“According to the NICD and the professors from KwaZulu-Natal Research Innovation and Sequencing Platform were reporting to the National Coronavirus Command Council this morning and the information at this stage is that this variant still responds to the vaccines.
"It has been indicated that just one dose of the two-dose vaccine gives you 80% protection and when you get your second dose, it gives you over 90% protection against serious illness. When you get infected when vaccinated, you carry less volume of viruses and you also transmit less.”
C.1.2: New Covid19 variant will not impact vaccine efficacy, say experts
In a related article on the pandemic, Briefly News reported that the C.1.2 Covid-19 variant is reportedly unlikely to stop current Covid-19 vaccines from preventing severe infections or death.
The news comes from scientists working at the National Institute for Communicable Diseases (NICD). The NICD reportedly held a media briefing on Thursday evening to ensure members of the public that they are keeping a close eye on the C.1.2 variant.
The NICD, according to TimesLIVE, revealed that there was cause to believe that the new variant will derange the efficacy of both the Johnson & Johnson and Pfizer vaccines.
These are the two Covid-19 vaccines that are being administered in South Africa.
In other news, Briefly News also reported that South African researchers have identified a coronavirus lineage they named C.1.2. The lineage has reportedly been detected in all provinces. Not much is known about the lineage yet and as a result, the World Health Organisation cannot declare C.1.2 a variant, however, it has the potential of becoming a variant like the Delta variant, according to a report by MoneyWeb.
Source: Briefly News
